BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24905390)

  • 1. Molecular characterization of chordoma xenografts generated from a novel primary chordoma cell source and two chordoma cell lines.
    Karikari IO; Gilchrist CL; Jing L; Alcorta DA; Chen J; Richardson WJ; Gabr MA; Bell RD; Kelley MJ; Bagley CA; Setton LA
    J Neurosurg Spine; 2014 Sep; 21(3):386-93. PubMed ID: 24905390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chordoma-derived cell line U-CH1-N recapitulates the biological properties of notochordal nucleus pulposus cells.
    Fujita N; Suzuki S; Watanabe K; Ishii K; Watanabe R; Shimoda M; Takubo K; Tsuji T; Toyama Y; Miyamoto T; Horiuchi K; Nakamura M; Matsumoto M
    J Orthop Res; 2016 Aug; 34(8):1341-50. PubMed ID: 27248133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and characterization of a chordoma cell line from the tissue of a patient with dedifferentiated-type chordoma.
    Kim JY; Lee J; Koh JS; Park MJ; Chang UK
    J Neurosurg Spine; 2016 Nov; 25(5):626-635. PubMed ID: 27314550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target.
    Hsu W; Mohyeldin A; Shah SR; ap Rhys CM; Johnson LF; Sedora-Roman NI; Kosztowski TA; Awad OA; McCarthy EF; Loeb DM; Wolinsky JP; Gokaslan ZL; Quiñones-Hinojosa A
    J Neurosurg; 2011 Oct; 115(4):760-9. PubMed ID: 21699479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study.
    Presneau N; Shalaby A; Ye H; Pillay N; Halai D; Idowu B; Tirabosco R; Whitwell D; Jacques TS; Kindblom LG; Brüderlein S; Möller P; Leithner A; Liegl B; Amary FM; Athanasou NN; Hogendoorn PC; Mertens F; Szuhai K; Flanagan AM
    J Pathol; 2011 Feb; 223(3):327-35. PubMed ID: 21171078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue microarray immunohistochemical detection of brachyury is not a prognostic indicator in chordoma.
    Zhang L; Guo S; Schwab JH; Nielsen GP; Choy E; Ye S; Zhang Z; Mankin H; Hornicek FJ; Duan Z
    PLoS One; 2013; 8(9):e75851. PubMed ID: 24086644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brachyury gene copy number gain and activation of the PI3K/Akt pathway: association with upregulation of oncogenic Brachyury expression in skull base chordoma.
    Otani R; Mukasa A; Shin M; Omata M; Takayanagi S; Tanaka S; Ueki K; Saito N
    J Neurosurg; 2018 May; 128(5):1428-1437. PubMed ID: 28753115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis.
    Oakley GJ; Fuhrer K; Seethala RR
    Mod Pathol; 2008 Dec; 21(12):1461-9. PubMed ID: 18820665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UM-Chor1: establishment and characterization of the first validated clival chordoma cell line.
    Owen JH; Komarck CM; Wang AC; Abuzeid WM; Keep RF; McKean EL; Sullivan S; Fan X; Prince MEP
    J Neurosurg; 2018 Mar; 128(3):701-709. PubMed ID: 28430034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel chordoma xenograft allows in vivo drug testing and reveals the importance of NF-κB signaling in chordoma biology.
    Trucco MM; Awad O; Wilky BA; Goldstein SD; Huang R; Walker RL; Shah P; Katuri V; Gul N; Zhu YJ; McCarthy EF; Paz-Priel I; Meltzer PS; Austin CP; Xia M; Loeb DM
    PLoS One; 2013; 8(11):e79950. PubMed ID: 24223206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the Cohesive Cluster Phenotype in Chordoma via β1 Integrin Increases Ionizing Radiation Efficacy.
    Harryman WL; Gard JMC; Pond KW; Simpson SJ; Heppner LH; Hernandez-Cortes D; Little AS; Eschbacher JM; Cress AE
    Neoplasia; 2017 Nov; 19(11):919-927. PubMed ID: 28954241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases.
    Sangoi AR; Karamchandani J; Lane B; Higgins JP; Rouse RV; Brooks JD; McKenney JK
    Mod Pathol; 2011 Mar; 24(3):425-9. PubMed ID: 21102418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival.
    Hu Y; Mintz A; Shah SR; Quinones-Hinojosa A; Hsu W
    Carcinogenesis; 2014 Jul; 35(7):1491-9. PubMed ID: 24445144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury.
    Magnaghi P; Salom B; Cozzi L; Amboldi N; Ballinari D; Tamborini E; Gasparri F; Montagnoli A; Raddrizzani L; Somaschini A; Bosotti R; Orrenius C; Bozzi F; Pilotti S; Galvani A; Sommer J; Stacchiotti S; Isacchi A
    Mol Cancer Ther; 2018 Mar; 17(3):603-613. PubMed ID: 29237806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting chordoma with brachyury, a "new age" marker: analysis of a validation study on 51 cases.
    Jambhekar NA; Rekhi B; Thorat K; Dikshit R; Agrawal M; Puri A
    Arch Pathol Lab Med; 2010 Aug; 134(8):1181-7. PubMed ID: 20670140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brachyury expression in intracranial SMARCB1-deficient tumors: important points for distinguishing poorly differentiated chordoma from atypical teratoid/rhabdoid tumor.
    Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Oda Y
    Hum Pathol; 2021 Jun; 112():1-8. PubMed ID: 33741347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas: An Immunohistochemical Study of 5229 Cases.
    Miettinen M; Wang Z; Lasota J; Heery C; Schlom J; Palena C
    Am J Surg Pathol; 2015 Oct; 39(10):1305-12. PubMed ID: 26099010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poorly differentiated extra-axial extraskeletal chordoma diagnosed by methylation profiling: case report and analysis of brachyury expression in SWI/SNF-deficient tumors.
    Klubíčková N; Michal M; Kinkor Z; Soukup J; Ryška A; Brtková J; Lutonský M; Hájková V; Ptáková N; Michal M; Farkas M; Švajdler M
    Virchows Arch; 2024 Apr; 484(4):621-627. PubMed ID: 37594643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and analysis of human chordoma cell lines.
    Yang C; Hornicek FJ; Wood KB; Schwab JH; Choy E; Iafrate J; Rosenberg A; Nielsen GP; Xavier RJ; Mankin H; Duan Z
    Spine (Phila Pa 1976); 2010 Jun; 35(13):1257-64. PubMed ID: 20461036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brachyury: a diagnostic marker for the differential diagnosis of chordoma and hemangioblastoma versus neoplastic histological mimickers.
    Barresi V; Ieni A; Branca G; Tuccari G
    Dis Markers; 2014; 2014():514753. PubMed ID: 24591762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.